NO953011L - Fremgangsmåte ved fremstilling av taxanderivater og ammellomprodukter for dem - Google Patents

Fremgangsmåte ved fremstilling av taxanderivater og ammellomprodukter for dem

Info

Publication number
NO953011L
NO953011L NO953011A NO953011A NO953011L NO 953011 L NO953011 L NO 953011L NO 953011 A NO953011 A NO 953011A NO 953011 A NO953011 A NO 953011A NO 953011 L NO953011 L NO 953011L
Authority
NO
Norway
Prior art keywords
taxol
taxotere
analogues
side chain
modified
Prior art date
Application number
NO953011A
Other languages
English (en)
Norwegian (no)
Other versions
NO953011D0 (no
Inventor
Iwao Ojima
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of NO953011D0 publication Critical patent/NO953011D0/no
Publication of NO953011L publication Critical patent/NO953011L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO953011A 1993-02-01 1995-07-31 Fremgangsmåte ved fremstilling av taxanderivater og ammellomprodukter for dem NO953011L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1192293A 1993-02-01 1993-02-01
PCT/US1994/000669 WO1994018164A1 (fr) 1993-02-01 1994-01-28 PROCEDE DE PREPARATION DE DERIVES DE TAXANE ET INTERMEDIAIRES DE β-LACTAME UTILISES A CET EFFET

Publications (2)

Publication Number Publication Date
NO953011D0 NO953011D0 (no) 1995-07-31
NO953011L true NO953011L (no) 1995-09-21

Family

ID=21752542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953011A NO953011L (no) 1993-02-01 1995-07-31 Fremgangsmåte ved fremstilling av taxanderivater og ammellomprodukter for dem

Country Status (17)

Country Link
EP (1) EP0681568B1 (fr)
JP (1) JP3492367B2 (fr)
KR (1) KR960700226A (fr)
AT (1) ATE334115T1 (fr)
AU (1) AU687782B2 (fr)
CA (1) CA2154071C (fr)
CZ (1) CZ192195A3 (fr)
DE (1) DE69434801T2 (fr)
FI (1) FI953645A (fr)
MX (1) MX9400806A (fr)
NO (1) NO953011L (fr)
NZ (1) NZ261529A (fr)
PL (1) PL310075A1 (fr)
RU (1) RU95116366A (fr)
SK (1) SK90295A3 (fr)
WO (1) WO1994018164A1 (fr)
ZA (1) ZA94128B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US6232477B1 (en) 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
US6593482B2 (en) 1993-02-01 2003-07-15 Aventis Pharma S.A. Methods for preparing new taxoids and pharmaceutical compositions containing them
FR2732340B1 (fr) * 1995-03-27 1997-04-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6040466A (en) * 1996-03-25 2000-03-21 Rhone Poulenc Rorer Sa Taxoids, their preparation and pharmaceutical compositions containing them
CA2120221A1 (fr) * 1993-04-23 1994-10-24 Allan W. Rey 2-azetidinones substituees en n
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
CA2162759A1 (fr) * 1994-11-17 1996-05-18 Kenji Tsujihara Derives de la baccatine et methodes de preparation
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
WO1998025895A1 (fr) * 1996-12-13 1998-06-18 Eli Lilly And Company Inhibiteurs de l'activite enzymatique de l'antigene psa
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
EP1919926A2 (fr) 2005-06-10 2008-05-14 Florida State University Research Foundation, Inc. Procedes pour produire des composes a cycles fusionnes polycycliques
JP5113745B2 (ja) 2005-06-10 2013-01-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド ドセタキセルの製造法
DK2493466T3 (da) 2009-10-29 2021-04-26 Sanofi Mature Ip Hidtil ukendt antitumoral anvendelse af cabazitaxel
AU2012311050A1 (en) 2011-09-21 2014-03-06 Stem Cell Medicine Ltd. Beta-lactam compounds for treating diabetes
AU2012311051A1 (en) 2011-09-21 2014-03-06 Stem Cell Medicine Ltd. Beta-lactam compounds for enhancing T cell -mediated immune responses
CN102408356A (zh) * 2011-09-28 2012-04-11 北京东方协和医药生物技术有限公司 一种多西他赛手性侧链中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
CA2071160A1 (fr) * 1991-07-31 1993-02-01 Vittorio Farina Synthese asymetrique d'une chaine laterale du taxol
KR100239201B1 (ko) * 1991-09-23 2000-02-01 로버트 엠 존슨 10-데스아세톡시탁솔 유도체
HU226369B1 (en) * 1991-09-23 2008-09-29 Univ Florida State Process for preparing substituted isoserine-esters using metal alkoxides and beta-lactams
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
RU95116366A (ru) 1997-06-10
DE69434801T2 (de) 2007-08-09
AU6031394A (en) 1994-08-29
KR960700226A (ko) 1996-01-19
SK90295A3 (en) 1996-05-08
DE69434801D1 (de) 2006-09-07
WO1994018164A1 (fr) 1994-08-18
AU687782B2 (en) 1998-03-05
JPH08506339A (ja) 1996-07-09
EP0681568B1 (fr) 2006-07-26
CA2154071C (fr) 2005-06-28
FI953645A (fi) 1995-09-27
NO953011D0 (no) 1995-07-31
MX9400806A (es) 1994-08-31
CA2154071A1 (fr) 1994-08-18
CZ192195A3 (en) 1995-12-13
EP0681568A1 (fr) 1995-11-15
JP3492367B2 (ja) 2004-02-03
FI953645A0 (fi) 1995-07-31
ZA94128B (en) 1994-08-19
ATE334115T1 (de) 2006-08-15
PL310075A1 (en) 1995-11-27
NZ261529A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
NO953011D0 (no) Fremgangsmåte ved fremstilling av taxanderivater og ammellomprodukter for dem
FI970271A0 (fi) Puolisynteettiset taksaanit, joilla on kasvaimenvastainen vaikutus
PT674630E (pt) 7-halo- e 7beta,8beta-metano-taxois utilizacao antineoplasica e composicoes farmaceuticas que os contem
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
FI951596A (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
NO981823L (no) Mellomprodukter for hemisyntese av taxaner og fremstilling derav
IL145639A0 (en) C10 heterosubstituted acetate taxanes as antitumor agents
HK1026851A1 (en) Dolastatin-15 derivatives in combination with taxanes.
PL350331A1 (en) C10 carbamoyloxy substituted taxanes as antitumor agents
ATE392422T1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
IT1274356B (it) Tassani semisintetici odtati di attivita' antitumorale